Correction: A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy

Zhengze Lu; Yang Long; Xingli Cun; Xuhui Wang; Jianping Li; Ling Mei; Yiliang Yang; Man Li; Zhirong Zhang; Qin He

doi:10.1039/D5NR90093J

Correction: A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy

Zhengze Lu,^a Yang Long,^a Xingli Cun,^a Xuhui Wang,^a Jianping Li,^a Ling Mei,^a Yiliang Yang,^a Man Li,^a Zhirong Zhang^a and Qin He*^a

Author affiliations

* Corresponding authors

^a Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu 610041, China
E-mail: qinhe@scu.edu.cn
Fax: +86-28-85502532
Tel: +86-28-85502532

Abstract

Correction for ‘A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy’ by Zhengze Lu et al., Nanoscale, 2018, 10, 9957–9970, https://doi.org/10.1039/C8NR01184B.

Nanoscale

Correction: A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy

Social activity

Search articles by author

Spotlight

Advertisements